Bank of America
KYNB

Bank of America’s Kyntra Bio KYNB Stock Holding History

Bank of America’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-595
Closed -$5.22K – 6121
2025
Q4 		$5.22K Hold
595
– – ﹤0.01% 6267
2025
Q3 		$7.29K Buy
595
+152
+34% +$1.43K ﹤0.01% 7247
2025
Q2 		$2.35K Buy
443
+3
+0.7% +$22 ﹤0.01% 7413
2025
Q1 		$3.4K Sell
440
-138
-24% -$1.66K ﹤0.01% 7270
2024
Q4 		$7.65K Sell
578
-561
-49% -$5.21K ﹤0.01% 7030
2024
Q3 		$11.4K Sell
1,139
-5,296
-82% -$79.9K ﹤0.01% 6866
2024
Q2 		$144K Sell
6,435
-2,243
-26% -$69.3K ﹤0.01% 6057
2024
Q1 		$510K Sell
8,678
-1,901
-18% -$81.9K ﹤0.01% 5335
2023
Q4 		$234K Buy
10,579
+4,701
+80% +$70.9K ﹤0.01% 5987
2023
Q3 		$127K Sell
5,878
-15,338
-72% -$602K ﹤0.01% 6141
2023
Q2 		$1.43M Buy
21,216
+5,579
+36% +$2.31M ﹤0.01% 4503
2023
Q1 		$7.29M Buy
15,637
+1,780
+13% +$942K ﹤0.01% 3139
2022
Q4 		$5.55M Buy
13,857
+5,694
+70% +$2.18M ﹤0.01% 3299
2022
Q3 		$2.65M Buy
8,163
+3,103
+61% +$999K ﹤0.01% 4027
2022
Q2 		$1.34M Sell
5,060
-10,303
-67% -$2.63M ﹤0.01% 4651
2022
Q1 		$4.62M Buy
15,363
+6,970
+83% +$2.43M ﹤0.01% 3723
2021
Q4 		$2.96M Buy
8,393
+5,639
+205% +$1.76M ﹤0.01% 4179
2021
Q3 		$704K Sell
2,754
-1,468
-35% -$520K ﹤0.01% 5369
2021
Q2 		$2.81M Sell
4,222
-6,523
-61% -$3.76M ﹤0.01% 4040
2021
Q1 		$9.32M Buy
10,745
+2,299
+27% +$2.45M ﹤0.01% 2798
2020
Q4 		$7.83M Sell
8,446
-2,607
-24% -$2.74M ﹤0.01% 2730
2020
Q3 		$11.4M Buy
11,053
+2,260
+26% +$2.43M ﹤0.01% 2183
2020
Q2 		$8.91M Sell
8,793
-1,560
-15% -$1.45M ﹤0.01% 2321
2020
Q1 		$8.99M Buy
10,353
+861
+9% +$856K ﹤0.01% 2145
2019
Q4 		$10.2M Sell
9,492
-2,300
-20% -$2.35M ﹤0.01% 2539
2019
Q3 		$10.9M Sell
11,792
-2,560
-18% -$2.81M ﹤0.01% 2414
2019
Q2 		$16.2M Sell
14,352
-2,573
-15% -$2.82M ﹤0.01% 2063
2019
Q1 		$23M Buy
16,925
+13,127
+346% +$17.8M ﹤0.01% 1696
2018
Q4 		$4.39M Buy
3,798
+793
+26% +$891K ﹤0.01% 3136
2018
Q3 		$4.56M Sell
3,005
-1,371
-31% -$2.11M ﹤0.01% 3255
2018
Q2 		$6.85M Buy
4,376
+492
+13% +$641K ﹤0.01% 2836
2018
Q1 		$4.49M Buy
3,884
+525
+16% +$691K ﹤0.01% 3183
2017
Q4 		$3.98M Sell
3,359
-3,631
-52% -$4.55M ﹤0.01% 3327
2017
Q3 		$9.4M Buy
6,990
+4,051
+138% +$4.27M ﹤0.01% 2566
2017
Q2 		$2.37M Sell
2,939
-1,202
-29% -$837K ﹤0.01% 3730
2017
Q1 		$2.55M Buy
4,141
+99
+2% +$60.3K ﹤0.01% 3662
2016
Q4 		$2.16M Sell
4,042
-7,857
-66% -$3.92M ﹤0.01% 3708
2016
Q3 		$6.16M Buy
11,899
+2,853
+32% +$1.34M ﹤0.01% 2644
2016
Q2 		$3.71M Sell
9,046
-11,489
-56% -$5.26M ﹤0.01% 3064
2016
Q1 		$10.9M Buy
20,535
+3,620
+21% +$1.8M ﹤0.01% 2066
2015
Q4 		$12.9M Buy
16,915
+15,241
+910% +$10.1M ﹤0.01% 2031
2015
Q3 		$917K Buy
1,674
+25
+2% +$15.1K ﹤0.01% 4383
2015
Q2 		$969K Buy
1,649
+1,638
+14,891% +$953K ﹤0.01% 4138
2015
Q1 		$8K Buy
11
+3
+38% +$2.33K ﹤0.01% 6366
2014
Q4 		$5K Buy
+8
New +$5.15K ﹤0.01% 7274

Other funds holding KYNB

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Bank of America's KYNB Position: Q1 2026 in Review

Bank of America sold out of Kyntra Bio (KYNB) in Q1 2026, closing a stake of 595 shares — an estimated $5.22K sold.

Bank of America first reported a position in KYNB in Q4 2014 and held it in 45 quarters. The position peaked at $23M in Q1 2019. 32 funds tracked by Wall St. Rank hold KYNB as of Q1 2026.

  • Bank of America reported no remaining Kyntra Bio position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 595 Kyntra Bio shares in Q1 2026, an estimated $5.22K.
  • Bank of America first reported a position in Kyntra Bio in Q4 2014 and held it in 45 quarters.
  • Bank of America's Kyntra Bio position peaked at $23M in Q1 2019.
  • 32 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.